About Advanced Ophthalmology Technologies-
Advanced ophthalmology technologies refer to cutting-edge equipment, tools, and techniques used in the field of ophthalmology, the branch of medicine specializing in eye care. These advancements aim to improve the diagnosis, treatment, and management of various eye conditions and disorders, leading to better patient outcomes and vision preservation. The advanced ophthalmology technologies market is experiencing positive growth due to a combination of demographic, technological, and economic factors. This growth is expected to continue in the foreseeable future, driven by the continuous need for improved eye care solutions.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. This market has various growth opportunities that leading players capture via tracking the ongoing process enhancement and huge investment in market growth strategies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Advanced Ophthalmology Technologies- market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Johnson & Johnson Services, Inc. (United States), Novartis AG (Switzerland), Alimera Sciences (United States), Teva Pharmaceutical Industries Ltd. (Israel), Bausch + Lomb (Canada), CooperVision (United States), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Essilor International S.A. (France) and Ziemer Ophthalmic Systems AG (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are NIDEK CO., LTD. (United States), TOPCON CORPORATION (Japan), Haag-Streit (Switzerland), HOYA Corporation (Japan) and Staar Surgical (United States).
Segmentation Overview
AMA Research has segmented the market of Global Advanced Ophthalmology Technologies- market by Type (Diagnostic (Optical Coherence Tomography Scanners, Ophthalmic Ultrasound Imaging Systems, Wavefront Aberrometers, Optical Biometry Systems, Corneal Topography, Specular, others) and Therapeutic (Ophthalmic Lasers, Surgical Devices)), Application (Cataract Surgery, Refractive Surgery, Glaucoma Surgery and Others) and Region.
On the basis of geography, the market of Advanced Ophthalmology Technologies- has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals and Clinics will boost the Advanced Ophthalmology Technologies- market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Adoption of Robotic Surgery
Market Growth Drivers:
Rising Prevalence of Eye Diseases and Growing Awareness and Early Diagnosis
Challenges:
Lack of Skilled Professionals
Restraints:
Limited Reimbursement and High Cost of Technologies
Opportunities:
Focus on Minimally Invasive Procedures, Untapped Potential in Emerging Markets and Gene Therapy for Eye Diseases
Market Leaders and their expansionary development strategies
In December 2023, Carl Zeiss Meditec AG, the medical technology arm of Zeiss, acquired the Dutch Ophthalmic Research Center (DORC). This acquisition will expand Zeiss's portfolio in the vitreoretinal surgery segment, complementing their existing ophthalmic devices.
In November 2023, Bausch + Lomb announced the launch of three new ophthalmic technologies. The first is enVista Aspire monofocal and toric IOLs, with intermediate optimised optics. The second is eyeTELLIGENCE surgical planning software. The third is the SeeNa ophthalmic diagnostic device. This launched aim to improve patient outcomes and experiences in cataract surgery and dry eye management.
Key Target Audience
Research Center, Government Authorities, Potential Investors, Regulatory Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.